$123.52
2.41.98%
At Close: -
$123.52
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Addus HomeCare
ADUSNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Addus HomeCare (NASDAQ:ADUS) Stock, Analyst Ratings, Price Targets, Forecasts
Addus HomeCare Corp has a consensus price target of $115.5 based on the ratings of 11 analysts. The high is $136 issued by Macquarie on June 28, 2024. The low is $83 issued by Barclays on April 23, 2024. The 3 most-recent analyst ratings were released by Macquarie, TD Cowen, and Oppenheimer on June 28, 2024, June 18, 2024, and June 7, 2024, respectively. With an average price target of $131.33 between Macquarie, TD Cowen, and Oppenheimer, there's an implied 6.33% upside for Addus HomeCare Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Macquarie
TD Cowen
Oppenheimer
Stephens & Co.
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Addus HomeCare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/28/2024 | Buy Now | 10.1% | Macquarie | Tao Qiu | → $136 | Initiates | → Outperform | Get Alert |
| 06/18/2024 | Buy Now | 3.63% | TD Cowen | Ryan Langston | $119 → $128 | Maintains | Buy | Get Alert |
| 06/07/2024 | Buy Now | 5.25% | Oppenheimer | Michael Wiederhorn | $118 → $130 | Maintains | Outperform | Get Alert |
| 05/31/2024 | Buy Now | 3.63% | Stephens & Co. | Scott Fidel | $120 → $128 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | -3.66% | TD Cowen | Ryan Langston | $105 → $119 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | -6.9% | Stephens & Co. | Scott Fidel | → $115 | Reiterates | Overweight → Overweight | Get Alert |
| 05/07/2024 | Buy Now | -4.47% | B of A Securities | Joanna Gajuk | $115 → $118 | Maintains | Buy | Get Alert |
| 04/23/2024 | Buy Now | -32.8% | Barclays | Andrew Mok | → $83 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 03/26/2024 | Buy Now | -4.47% | Oppenheimer | Michael Wiederhorn | $118 → $118 | Maintains | Outperform | Get Alert |
| 03/06/2024 | Buy Now | -28.76% | Barclays | Andrew Mok | → $88 | Initiates | → Equal-Weight | Get Alert |
| 02/29/2024 | Buy Now | -17.42% | RBC Capital | Ben Hendrix | → $102 | Reiterates | Outperform → Outperform | Get Alert |
| 02/05/2024 | Buy Now | — | William Blair | Jared Haase | — | Assumes | → Outperform | Get Alert |
| 01/17/2024 | Buy Now | -4.47% | Oppenheimer | Michael Wiederhorn | → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 12/12/2023 | Buy Now | -14.99% | TD Cowen | Ryan Langston | → $105 | Initiates | → Outperform | Get Alert |
| 11/01/2023 | Buy Now | -17.42% | RBC Capital | Ben Hendrix | $109 → $102 | Maintains | Outperform | Get Alert |
| 11/01/2023 | Buy Now | -14.99% | Stephens & Co. | Scott Fidel | $110 → $105 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | -4.47% | Oppenheimer | Michael Wiederhorn | → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 08/02/2023 | Buy Now | -14.99% | Raymond James | John Ransom | $100 → $105 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | -10.95% | Stephens & Co. | Scott Fidel | $100 → $110 | Maintains | Overweight | Get Alert |
| 08/01/2023 | Buy Now | -19.04% | Stephens & Co. | Scott Fidel | → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 06/29/2023 | Buy Now | -4.47% | Oppenheimer | Michael Wiederhorn | $118 → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 05/26/2023 | Buy Now | -4.47% | Oppenheimer | Michael Wiederhorn | → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 05/05/2023 | Buy Now | -19.04% | Raymond James | John Ransom | $125 → $100 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | -11.76% | RBC Capital | Ben Hendrix | $123 → $109 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | -4.47% | Oppenheimer | Michael Wiederhorn | $130 → $118 | Maintains | Outperform | Get Alert |
| 05/02/2023 | Buy Now | -0.42% | Stephens & Co. | Scott Fidel | → $123 | Reiterates | → Overweight | Get Alert |
| 04/05/2023 | Buy Now | -0.42% | Stephens & Co. | Scott Fidel | → $123 | Reiterates | → Overweight | Get Alert |
| 03/06/2023 | Buy Now | -0.42% | RBC Capital | Ben Hendrix | $121 → $123 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | -2.04% | RBC Capital | Ben Hendrix | $110 → $121 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | 1.2% | Raymond James | John Ransom | $115 → $125 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | -10.95% | RBC Capital | Ben Hendrix | $111 → $110 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 5.25% | Oppenheimer | Michael Wiederhorn | $135 → $130 | Maintains | Outperform | Get Alert |
| 06/29/2022 | Buy Now | -18.23% | Stifel | Tao Qiu | → $101 | Initiates | → Buy | Get Alert |
| 06/21/2022 | Buy Now | -18.23% | Stephens & Co. | Scott Fidel | $110 → $101 | Maintains | Overweight | Get Alert |
| 05/04/2022 | Buy Now | -10.14% | RBC Capital | Ben Hendrix | $125 → $111 | Maintains | Outperform | Get Alert |
| 04/13/2022 | Buy Now | -10.95% | B of A Securities | Joanna Gajuk | → $110 | Initiates | → Buy | Get Alert |
| 03/10/2022 | Buy Now | 1.2% | RBC Capital | Ben Hendrix | $124 → $125 | Maintains | Outperform | Get Alert |
| 11/03/2021 | Buy Now | 0.39% | RBC Capital | Frank Morgan | — | Maintains | Outperform | Get Alert |
| 08/04/2021 | Buy Now | -6.9% | Raymond James | John Ransom | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Addus HomeCare (ADUS) stock?
The latest price target for Addus HomeCare (NASDAQ:ADUS) was reported by Macquarie on June 28, 2024. The analyst firm set a price target for $136.00 expecting ADUS to rise to within 12 months (a possible 10.10% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Addus HomeCare (ADUS)?
The latest analyst rating for Addus HomeCare (NASDAQ:ADUS) was provided by Macquarie, and Addus HomeCare initiated their outperform rating.
When was the last upgrade for Addus HomeCare (ADUS)?
There is no last upgrade for Addus HomeCare
When was the last downgrade for Addus HomeCare (ADUS)?
The last downgrade for Addus HomeCare Corp happened on April 23, 2024 when Barclays changed their price target from $88 to $83 for Addus HomeCare Corp.
When is the next analyst rating going to be posted or updated for Addus HomeCare (ADUS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Addus HomeCare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Addus HomeCare was filed on June 28, 2024 so you should expect the next rating to be made available sometime around June 28, 2025.
Is the Analyst Rating Addus HomeCare (ADUS) correct?
While ratings are subjective and will change, the latest Addus HomeCare (ADUS) rating was a initiated with a price target of $0.00 to $136.00. The current price Addus HomeCare (ADUS) is trading at is $123.52, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.